IGC Pharma Inc
IGC Pharma Inc (IGC) Option Chain
Read more
Tracking the IGC option chain helps you see every strike and expiry on IGC Pharma Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IGC options activity at a glance. Use our scanner to monitor the IGC option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IGC stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where IGC options are being actively traded, and where they are not.
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 99.15 | 1 | 0 | 0.05 | 0.00 | — | 0.05 | 2.50 | +1370.59 | 2.30 | 2.40 | 2.33 | 0.02 | 0 | 1 | 0.85 |
| 99.72 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 5.00 | +2841.18 | 4.80 | 4.90 | 4.83 | 0.02 | 0 | 0 | 0.28 |
| 99.86 | 0 | 0 | 0.75 | 0.00 | — | 0.75 | 7.50 | +4311.76 | 7.30 | 7.60 | 7.33 | 0.12 | 2 | 0 | 0.14 |
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank70.63% High
- Market cap (M$)20
- 52 weeks high-52.78%
- 52 weeks low112.50%
- Analyst recommendationStrong Buy
1.00 - Target price$6.00
3429.41% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-0.08
- EPS growth next 5 years—
As of Nov 20, 2026